Literature DB >> 2097517

Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tetrodotoxin, calcium and calcium antagonists.

T Sharp1, S R Bramwell, D G Grahame-Smith.   

Abstract

We have utilized the brain microdialysis technique in an attempt to measure excitation-secretion coupled release of endogenous 5-hydroxytryptamine in rat brain in vivo and investigated the pharmacology of the voltage-sensitive calcium channel involved in this process. All experiments were carried out using chloral hydrate anaesthetized rats. Ascending serotoninergic neurons were electrically stimulated using an electrode implanted into the dorsal raphe nucleus. A dialysis probe was implanted into the ventral hippocampus and continuously perfused with artificial cerebrospinal fluid containing the selective 5-hydroxytryptamine uptake inhibitor citalopram (1 microM). Twenty-minute perfusates were analysed for endogenous 5-hydroxytryptamine using high performance liquid chromatography with electrochemical detection. Electrical stimulation (cathodal monophasic 1 ms pulses, 300 microA, 2-10 Hz) of the dorsal raphe nucleus for 20 min induced an immediate release of 5-hydroxytryptamine which lasted for the duration of the stimulus and was frequency-dependent. The calculated amount of 5-hydroxytryptamine release per electrical impulse was constant over the frequency range used. Addition of tetrodotoxin (10 microM) to, or omission of calcium from, the perfusion medium reduced the spontaneous output of 5-hydroxytryptamine by 60-70% and caused a near complete inhibition of the effect of low frequency (3 Hz) electrical stimulation of the dorsal raphe nucleus. Local perfusion with cadmium (30 and 300 microM), which is reported to antagonize both N- and L-type voltage-sensitive calcium channels, also caused a pronounced decrease of basal output of 5-hydroxytryptamine and a marked, but not complete inhibition of the effect of nerve stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2097517     DOI: 10.1016/0306-4522(90)90247-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

2.  Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis.

Authors:  Begoña Fernández-Pastor; Yolanda Mateo; Sonia Gómez-Urquijo; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

3.  Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.

Authors:  J L Barr; G L Forster
Journal:  Neuroscience       Date:  2011-03-21       Impact factor: 3.590

4.  The source of physiologically stimulated glutamate efflux from the striatum of conscious rats.

Authors:  M Miele; M G Boutelle; M Fillenz
Journal:  J Physiol       Date:  1996-12-15       Impact factor: 5.182

5.  Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.

Authors:  F F Matos; C Urban; F D Yocca
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo.

Authors:  K F Martin; S Hannon; I Phillips; D J Heal
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

7.  Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus.

Authors:  J J O'Connor; Z L Kruk
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

8.  Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo.

Authors:  S E Gartside; P J Cowen; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Interleukin-1beta release in the supraoptic nucleus area during osmotic stimulation requires neural function.

Authors:  J Y Summy-Long; S Hu; A Long; T M Phillips
Journal:  J Neuroendocrinol       Date:  2008-08-22       Impact factor: 3.627

10.  The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.

Authors:  L Arborelius; G G Nomikos; P Hertel; P Salmi; P Grillner; B B Höök; U Hacksell; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.